Seventh Future Healthcare 100 Summit to Be Held in Zhangjiang in May 2023, Driving Medical Innovation
Currently, a new round of technological and industrial revolutions is accelerating, with breakthroughs in life sciences gaining momentum. The deep integration of the bio-industry and the information industry holds significant importance for the development of global health initiatives and the recovery of the world economy. Surpassing and catching up remain the consistent underlying theme of China's healthcare sector, as the country enters the stage with a renewed presence. To build an ecosystem for value exchange in medical health and facilitate coordinated industrial development,Shanghai Zhangjiang GroupandVCBeat VB100Jointly BuildThe 7th Future Healthcare Top 100 Conference, inMay 5-7, 2023Established in Zhangjiang, we pool high-quality resources from both parties to jointly build a communication and matchmaking platform for the entire healthcare industry chain, linking global intelligence, sharing cutting-edge technologies, inspiring the future of tech, and focusing on venture capital interaction.
The Future Healthcare Top 100 Conference has kept pace with the times, having successfully held six editions to date. It has witnessed the magnificent development of China’s big health industry and the rise of innovative forces across its value chain. This year’s conference is expected to attract 7,000 attendees. Three main forums will focus on trend strategies and innovation; coverage will span over 20 hot sectors, leading new breakthroughs in the future of healthcare; five authoritative ranking categories will identify the core strengths of the industry. The event will bring together strategic announcements from listed companies, outstanding global healthcare innovation projects, and scientific research achievements, enabling participants to sense the dynamics of industry capital and gain insights into the future landscape of healthcare innovation.
Attendees include academicians and experts, industry associations, research institutes, venture capital firms, and enterprises across the upstream and downstream of the healthcare sector, converging core industrial resources. The conference has identified 20+ hot topics across four major tracks: medical devices, biopharmaceuticals, digital health, and healthcare services. These topics cover visual imaging equipment, vascular intervention, ophthalmology, organoids and organ-on-a-chip, radiopharmaceuticals, AI-driven drug discovery, cell and gene therapy, digital marketing for pharmaceutical companies, nutritional science, synthetic biology, digital therapeutics, brain science, AI-assisted diagnosis, internet hospitals and smart hospitals, as well as health insurance and health management. The event is dedicated to discovering new technologies, new business formats, and new models in the broader health sector, jointly promoting long-term investment strategies in the health industry.
In the future city of medical innovation, we are charting the development blueprint for healthcare advancement. As the birthplace of China’s modern biopharmaceutical industry, Shanghai has gradually formed a “1+5+X” spatial layout for its biopharmaceutical sector, centered on the Zhangjiang Biopharmaceutical Innovation Core Area, against the backdrop of intensive policy rollouts. Over three decades of development, Zhangjiang Science City in Shanghai has emerged as a premier industrial hub in China’s biopharmaceutical landscape, characterized by a high concentration of R&D institutions, robust innovation capabilities, and outstanding achievements in new drug development. Meanwhile, VCBeat VB100, an industry service brand dedicated to the healthcare sector, accompanies innovative enterprises and the new generation of scientists in their growth, serving as their trusted partner. The Future Healthcare 100 Conference, a flagship event under VCBeat VB100, is set to lead trends in the current and coming years, becoming a bellwether for development, investment, and aggregation in China’s healthcare innovation arena.
In this context, Shanghai Zhangjiang Group andVCBeat VB100 Strategic Partnership，It will create an intellectual feast that integrates “cutting-edge academic and research insights, comprehensive industry perspectives, and keen awareness of capital market trends.” The Future Healthcare Top 100 Conference willJoin hands with peers to explore the innovative future of the broader health industry, better lead regional economic development, inject strong momentum into the innovative development of the medical and healthcare sector, and accelerate the establishment and digital transformation of Zhangjiang’s world-class biopharmaceutical industry cluster.
Highlights of the 7th Future Healthcare Top 100 Conference
Gathering of Industry Leaders from Government, Academia, Research, Business, Investment, and Finance
Academicians and IEEE Fellows, leading a cohort of nearly 300 industry luminaries, present the most cutting-edge medical technologies, industry trends, and business innovations;
6 Major Leaderboards, 3 Awards Announced
Top 100 Innovative Medical Devices, Top 100 Innovative Biopharmaceuticals, Top 100 Innovative Medical Services, Top 100 Innovative Digital Health, Top 100 Innovative Healthcare Commerce and Supply Chain Services, Top 100 Innovative Overseas Healthcare; the Weilan Awards, Pengcheng Awards, and Value Sector Awards were simultaneously released; gathering the core forces of future healthcare, with 1,000+ unicorns and high-potential innovative enterprises jointly exploring the path of innovative development;
Release of 1+N Industry Research Reports
"Analysis Report on the Growth of the Top 100 Future Healthcare Companies: Defining the Growth of Core Forces in Future Healthcare; Premier Release of 10+ Industry Research Series Reports, Covering Genetic Testing, Digital Pharmaceutical Marketing, Health Insurance, Organoids, Radiopharmaceuticals, Energy-Based Aesthetic Devices, and More, to Explore Development Opportunities and Innovative Cases in Niche Sectors;"
10+ Enterprises/Institutions Co-Creating an Industrial Innovation Ecosystem
The Top 100 Future Healthcare Conference has established in-depth collaborations with Proxima Ventures, Boyuan Capital, CDH VGC, Fumilei, Fusote, GTJA Investment, Hetang Venture Capital, Huagai Capital, Huakong Fund, China Renaissance, Jinding Capital, Matrix Partners China, Legend Capital, Qiming Venture Partners, Weilai Capital, Wuyuan Capital, Industrial Securities Economic and Financial Research Institute, Yueyin Medical Fund, and Yunqueyi (listed in alphabetical order by Pinyin, not in order of importance) to jointly create an innovative ecosystem for the healthcare industry;
4 Formats, 7 Concurrent Events: Close-Up VC Exchange
Concurrently, the conference will host a Top 100 Gala Dinner, global innovation project pitch sessions and scientific achievement commercialization roadshows, corporate/product promotion events, closed-door seminars, an ecosystem summit, an exhibition for innovative startups, and a matchmaking area. These initiatives aim to build a comprehensive communication and networking platform for the entire healthcare industry chain, efficiently linking all key resources across academia, research, industry, and investment.
Shanghai Zhangjiang (Group) Co., Ltd. (formerly Shanghai Zhangjiang Hi-Tech Park Development Company) was established on July 28, 1992. As the “main force in development, promoter of emerging industries, and builder of the sci-tech innovation ecosystem” for Zhangjiang Science City, the Group is positioned as a premier comprehensive service provider for innovation ecosystems. Supported by sci-tech industry investment, services for sci-tech innovation enterprises, and the development and construction of the science city, it undertakes key functions including coordinated planning of development and construction, project attraction, industry cultivation, functional services, and fostering an atmosphere for innovation and entrepreneurship.
Zhangjiang Science City is located in the central part of Pudong New Area, Shanghai. With a planned area of 220 square kilometers, it brings together national laboratories, universities and research institutions, world-leading innovative enterprises, and talent resources. Currently, it hosts more than 24,000 enterprises, 179 national- and municipal-level R&D institutions, 66 regional headquarters of multinational corporations, and nearly 20 universities and research institutes, with over 499,000 employees. In the future, it will develop into a world-class science city characterized by “greater agglomeration of scientific research elements, more vibrant innovation and entrepreneurship, improved living services, more convenient transportation, a more beautiful ecological environment, and a richer cultural atmosphere.”
The Future Healthcare Top 100 Conference is the largest and most information-rich summit in China’s healthcare innovation industry, fostering the integration of industry and capital. It aims to gather core industrial forces, drive transformative change in the innovative healthcare sector, and build a comprehensive communication and matchmaking platform for the entire healthcare ecosystem. The 5th Future Healthcare Top 100 Conference (offline) attracted over 7,000 attendees, while the 6th edition (online) drew more than 35,000 participants. Over the past six years, the conference system has been continuously upgraded, gradually evolving into an innovative ecological summit that connects innovative enterprises, industrial capital, healthcare service providers, research universities, and industrial parks. Themed “Beyond East and West,” the 7th Future Healthcare Top 100 Conference outlines the era’s landscape where China’s medical health research is closely linked and positively interacts with the construction of its public health system. It records the historical strides of China’s medical health innovation and showcases the spirit of confidence, resilience, and unwavering progress—transcending geographical boundaries—within China’s healthcare sector.
Conference Name:The 7th Future Healthcare Top 100 Conference
Conference Schedule:May 5–7, 2023
Conference Venue:China · Shanghai Zhangjiang Science Hall
Conference Format:Offline Summit
Conference Scale:Projected 7,000 visits
Organizational Structure:
Organizers: VCBeat VB100, Eggshell Research Institute
Strategic Partner: Shanghai Zhangjiang Group
